Physician
Hillsdale Pulmonary Critical Care and Sleep Medicine PC
Hillsdale Pulmonary Critical Care and Sleep Medicine PC was paid $4.78M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoHILLSDALE PULMONARY CRITICAL CARE AND SLEEP MEDICINE PC
HILLSDALE, MI 49242
HILLSDALE, MI 49242
33aNPI1730361254assigned 11/27/2007
33bProvider typePulmonary Disease Physician
28Total paid$4.78M
24GClaims142,199
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pulmonary Disease Physician providers in Michigan
Rank by total paid#3 of 63
Median peer was paid$118K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,941 | $476K | |
| 2019 | 35,654 | $609K | |
| 2020 | 13,204 | $570K | |
| 2021 | 15,774 | $776K | |
| 2022 | 17,544 | $858K | |
| 2023 | 19,851 | $827K | |
| 2024incomplete | 17,231 | $667K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 43,910 | 36,240 | $2.38M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 15,861 | 14,103 | $1.18M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.3% | 2,937 | 2,892 | $206K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.9% | 5,275 | 4,916 | $185K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.5% | 1,274 | 1,265 | $122K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.9% | 907 | 896 | $92K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.8% | 1,131 | 710 | $88K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.8% | 972 | 971 | $84K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 1,202 | 476 | $45K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 871 | 863 | $41K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 470 | 450 | $34K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,650 | 2,996 | $30K |
68 more codes
| 90791 | Psychiatric diagnostic evaluation | <1% | 254 | $29K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 706 | $28K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 206 | $24K |
| 90674 | <1% | 726 | $21K | |
| 76942 | <1% | 800 | $20K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,811 | $19K |
| 94729 | <1% | 557 | $13K | |
| 94060 | <1% | 617 | $13K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 143 | $12K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,082 | $12K |
| 99441 | <1% | 394 | $10K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,713 | $10K |
| 87631 | <1% | 88 | $8K | |
| 93000 | <1% | 838 | $7K | |
| 20552 | <1% | 298 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 530 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 334 | $6K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 64 | $6K |
| 90661 | <1% | 154 | $5K | |
| 96130 | <1% | 92 | $4K | |
| 99406 | <1% | 388 | $3K | |
| 99223 | Prolong inpt eval add15 m | <1% | 31 | $3K |
| 99442 | <1% | 82 | $3K | |
| 94727 | <1% | 107 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 44 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,619 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,223 | $2K |
| 81003 | <1% | 1,204 | $2K | |
| 95117 | <1% | 312 | $2K | |
| 94726 | <1% | 80 | $1K | |
| 99221 | <1% | 24 | $1K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 63 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 413 | $1K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 23 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 91 | $1K |
| 90688 | <1% | 70 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13 | $1K |
| 81025 | <1% | 148 | $984.06 | |
| 90686 | <1% | 56 | $928.29 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 192 | $788.70 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $684.08 |
| 96137 | <1% | 24 | $666.76 | |
| 92228 | <1% | 34 | $534.24 | |
| 96136 | <1% | 19 | $464.44 | |
| 99217 | <1% | 14 | $455.25 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 32 | $335.85 |
| 81002 | <1% | 134 | $315.88 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 13 | $272.58 |
| 82044 | <1% | 42 | $187.99 | |
| 94760 | <1% | 11,033 | $106.76 | |
| 98966 | <1% | 24 | $44.30 | |
| 3078F | 0% | 2,385 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 11,093 | $0.00 |
| 1159F | 0% | 181 | $0.00 | |
| 3077F | 0% | 1,749 | $0.00 | |
| 2028F | 0% | 362 | $0.00 | |
| 3725F | 0% | 69 | $0.00 | |
| 3075F | 0% | 1,351 | $0.00 | |
| 3080F | 0% | 1,161 | $0.00 | |
| 3011F | 0% | 365 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 2,976 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 565 | $0.00 |
| 3079F | 0% | 1,877 | $0.00 | |
| 3008F | 0% | 5,230 | $0.00 | |
| 3074F | 0% | 2,930 | $0.00 | |
| 2000F | 0% | 2,415 | $0.00 | |
| 1111F | 0% | 12 | $0.00 | |
| G9007 | Coordinated care fee, scheduled team conference | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABDELKARIM, TARIQ (OWNER)